BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25311472)

  • 1. Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
    Sereni MI; Baldelli E; Gambara G; Deng J; Zanotti L; Bandiera E; Bignotti E; Ragnoli M; Tognon G; Ravaggi A; Meani F; Memo M; Angioli R; Liotta LA; Pecorelli SL; Petricoin E; Pierobon M
    Proteomics; 2015 Jan; 15(2-3):365-73. PubMed ID: 25311472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
    Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
    J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer.
    Mittermeyer G; Malinowsky K; Beese C; Höfler H; Schmalfeldt B; Becker KF; Avril S
    PLoS One; 2013; 8(10):e77825. PubMed ID: 24204986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
    Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
    Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.
    Hou S; Du P; Wang P; Wang C; Liu P; Liu H
    Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
    Wang D; Zhu H; Ye Q; Wang C; Xu Y
    Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.
    Basal E; Ayeni T; Zhang Q; Langstraat C; Donahoe PK; Pepin D; Yin X; Leof E; Cliby W
    Curr Mol Med; 2016; 16(3):222-31. PubMed ID: 26917267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTN signaling: Components and mechanistic insights in human ovarian cancer.
    Sethi G; Kwon Y; Burkhalter RJ; Pathak HB; Madan R; McHugh S; Atay S; Murthy S; Tawfik OW; Godwin AK
    Mol Carcinog; 2015 Dec; 54(12):1772-85. PubMed ID: 25418856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
    Ye J; Chen W; Wu ZY; Zhang JH; Fei H; Zhang LW; Wang YH; Chen YP; Yang XM
    Oncol Rep; 2016 Dec; 36(6):3588-3596. PubMed ID: 27779718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response.
    Pinciroli P; Alberti C; Sensi M; Canevari S; Tomassetti A
    BMC Genomics; 2013 Jul; 14():508. PubMed ID: 23889749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
    Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
    Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
    Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
    Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
    J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.